Delivery Order 36F79720D0017-36C24925F0123
Award Date
2/20/25
Potential Completion Date
3/31/25
Potential Value
$20K
Federal Agency
Veterans Integrated Service Network 9
Awardee
Dompe U.s. Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Mateo, CA 94402, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Dompe U.S. Inc., a foreign-owned pharmaceutical manufacturer, to provide the ophthalmic solution Oxervate. The order, valued at $19,887.06, was made against the GSA Pharmaceuticals and Drugs schedule (FSS-61-IB) and will fulfill urgent medication needs at VA facilities through the agency's Veterans Integrated Service Network 19. Dompe U.S. Inc. has previously received other VA contracts and...
This is a delivery order awarded to Dompe U.S. Inc., a foreign-owned for-profit pharmaceutical manufacturer, by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9). The delivery order, valued at $19,887.06, is for the provision of Oxervate, an ophthalmic solution used to treat neurotrophic keratitis. The order was placed against Dompe U.S. Inc.'s General Services Administration (GSA) Pharmaceuticals and Drugs schedule contract (FSS-61-IB), a...
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Dompe U.S. Inc., a foreign-owned, for-profit pharmaceutical manufacturer, against the General Services Administration (GSA) Pharmaceuticals and Drugs schedule (FSS-61-IB). The $19,887.06 firm fixed price order is for the supply of Oxervate, an ophthalmic solution used to treat neurotrophic keratitis. This award is not set-aside and is part of a larger $2.4 million blanket purchase agreement Dompe holds with the VA...
The Department of Veterans Affairs (VA) awarded a $159,096.48 firm fixed price delivery order to Dompe U.S. Inc., a foreign-owned pharmaceutical manufacturer, to provide the ophthalmic solution Oxervate for emergency patient treatment. This order was placed against Dompe's existing Pharmaceuticals and Drugs schedule contract (FSS-61-IB) with the General Services Administration (GSA). Dompe also holds a $2.4 million blanket purchase agreement with the VA National Acquisition Center specifically...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $70,914.40 delivery order to Dompe U.S. Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for the emergency drug OXERVATE and has a completion date of January 3, 2022. Placed against GSA Schedule FSS-61-IB, the award utilizes the schedule's pre-negotiated pricing terms for pharmaceutical products to fulfill an immediate need for...
This delivery order against the Pharmaceuticals and Drugs schedule, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12, is for $18,030.08 of OXERVATE 0.002% solution for opthalmic use. The prime contractor is Dompe U.s. Inc. located in San Mateo, California. The order was awarded on February 15, 2022 with a completion date of March 15, 2022. It utilizes firm fixed pricing and has no set-aside designation. The delivery order was...
This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to Dompe U.S. Inc. for the provision of OXERVATE 0.002% ophthalmic solution. With a potential value of $70,344.24 and a completion date of October 10, 2020, this firm fixed price contract calls for Dompe U.S. Inc. to deliver the specified pharmaceutical product to locations within Boston,...
This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to Dompe U.S. Inc. for the provision of OXERVATE 0.002% ophthalmic solution. With a potential value of $17,728.60 and a completion date of January 5, 2022, this firm fixed price order is for the delivery of the specified pharmaceutical to support care provided by VISN 20, which serves veterans...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $72,120.32 delivery order to Dompe U.s. Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with performance in San Mateo, California. The order is for the specialty drug OXERVATE to support VHA pharmacy programs, with a firm fixed price and completion by March 4, 2022. No set-aside designation was used for this award placed against the GSA...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide OXERVATE 0.002% eye drops. The contract has a potential value of $149,388.16 and a completion date of June 30, 2023. As a prime contractor, Accredo Health Group supports the VHA by delivering specialty pharmaceutical products to VA medical centers and facilities nationwide....